Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Link opens in a new tab
Search content at UTMB Health Research Expert Profiles
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Immunomodulation: The future of allergy and asthma treatment
R. Matthew Bloebaum
, J. Andrew Grant
, Sanjiv Sur
Research output
:
Contribution to journal
›
Review article
›
peer-review
24
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Immunomodulation: The future of allergy and asthma treatment'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Allergic Diseases
100%
Asthma Treatment
100%
Immunomodulation
100%
Allergy Treatment
100%
Immune System
40%
United States
20%
Immune Response
20%
Etiology
20%
DNA Sequencing
20%
Murine Model
20%
Signaling Molecules
20%
Guanine
20%
Future Therapies
20%
Human Trials
20%
Chemokine Receptor
20%
Dinucleotide
20%
Allergic Asthma
20%
Effective Treatment
20%
Adhesion Molecules
20%
Cytosine
20%
Treatment Modalities
20%
Cytokine Receptor
20%
Allergic Reaction
20%
Targeted Therapy
20%
Asthma Disease
20%
Immunosuppressive Therapy
20%
Bacterial DNA
20%
Non-allergic
20%
Anti-IgE Antibody
20%
Cytokines/chemokines
20%
Disease-modifying Agents
20%
Pharmacology, Toxicology and Pharmaceutical Science
Asthma
100%
Immunomodulation
100%
Allergy
100%
Allergic Disease
100%
Diseases
50%
Guanine
25%
Cytokine
25%
Prevalence
25%
Dinucleotide
25%
Morbidity
25%
Cytosine
25%
Chemokine Receptor
25%
Immunoglobulin E Antibody
25%
Allergic Reaction
25%
Allergic Asthma
25%
Monoclonal Anti-IgE
25%
Bacterial DNA
25%
Cytokine Receptor
25%
Cell Adhesion Proteins
25%
Etiology
25%
Immunology and Microbiology
Asthma
100%
Immunomodulation
100%
Allergic Disease
100%
Allergy
100%
Immune System
50%
Immune Response
25%
Cytokine
25%
Downregulation
25%
Prevalence
25%
Immunoglobulin E Antibody
25%
Chemokine Receptor
25%
Allergic Asthma
25%
DNA Sequence
25%
Cytokine Receptor
25%
Hypersensitive Response
25%
Morbidity
25%
Cell Adhesion Proteins
25%
Monoclonal Anti-IgE
25%
Medicine and Dentistry
Monoclonal Anti-IgE
25%